financetom
JNJ
financetom
/
Healthcare
/
JNJ
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
Johnson & JohnsonJNJ
USD
- At close
USD
- Until the end
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
% Change
Description >

Johnson & Johnson, together with its subsidiaries, researches, develops, manufactures, and sells various products in the healthcare field worldwide.

The company's Consumer Health segment provides skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products.

This segment also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand.

It serves general public, retail outlets, and distributors. The company's Pharmaceutical segment provides products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; HIV/AIDS infectious diseases; mood disorders, neurodegenerative disorders, and schizophrenia; prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; thrombosis, diabetes, and macular degeneration; and pulmonary arterial hypertension.

This segment serves retailers, wholesalers, distributors, hospitals, and healthcare professionals directly for prescription use.

Its MedTech segment offers electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and contact lenses and ophthalmic technologies related to cataract and laser refractive surgery under the ACUVUE brand.

This segment serves wholesalers, hospitals, and retailers. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.

Latest News >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Italy economy minister says would quit if defied on UniCredit-BPM deal
Italy economy minister says would quit if defied on UniCredit-BPM deal
May 28, 2025
ROME (Reuters) -Italian Economy Minister Giancarlo Giorgetti said on Wednesday he would resign if he were overruled on golden power conditions the government has tied to UniCredit's bid for smaller bank Banco BPM. Giorgetti, from the hard-right League party, was speaking in the Senate after reports in Italian newspapers, citing government sources, suggested that changes in the conditions were possible,...
Okta Reiterates Fiscal 2026 Revenue Outlook Amid Economic Uncertainties; First-Quarter Results Top Views
Okta Reiterates Fiscal 2026 Revenue Outlook Amid Economic Uncertainties; First-Quarter Results Top Views
May 28, 2025
06:43 AM EDT, 05/28/2025 (MT Newswires) -- Okta ( OKTA ) recorded stronger-than-expected fiscal first-quarter results, while the cloud-based access management platform company reiterated its full-year revenue outlook and flagged potential risks related to an uncertain economic environment. The company continues to project revenue to come in between $2.85 billion and $2.86 billion for fiscal 2026, representing annual growth of...
Trump Says Working on Taking Mortgage Agencies Fannie Mae, Freddie Mac Public
Trump Says Working on Taking Mortgage Agencies Fannie Mae, Freddie Mac Public
May 28, 2025
06:41 AM EDT, 05/28/2025 (MT Newswires) -- President Donald Trump said Tuesday that his administration is working on taking government-sponsored mortgage agencies Fannie Mae and Freddie Mac public. I am working on taking these amazing companies public, but I want to be clear, the US government will keep its implicit guarantees, and I will stay strong in my position on...
Copyright 2023-2026 - www.financetom.com All Rights Reserved